Traci S. Umberger - 21 Oct 2026 Form 4 Insider Report for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)

Reporting relationship: General Counsel and Chief Adminstrative Officer, Director
Issuer ticker: KMTS
Reported as of: 21 Oct 2026
Net transaction value: -$2,718,318
SEC form: 4
Accepted by SEC: 22 Oct 2026, 16:26:36 UTC
Prior SEC filing: 06 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Traci S. Umberger

Filing notes and source

Key filing fact

Traci S. Umberger filed Form 4 for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) on 22 Oct 2026.

Key facts

This page summarizes Traci S. Umberger's Form 4 filing for KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS).
4 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 22 Oct 2026, 16:26.

Change

Previous filing in this sequence was filed on 06 Aug 2026.
Current net transaction value: -$2,718,318.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001877198 Primary reporting owner

Umberger Traci S

Relationship: General Counsel and Chief Adminstrative Officer, Director
Address: 3933 LAKE WASHINGTON BLVD NE, SUITE 200, KIRKLAND
Signature: /s/ Traci S. Umberger
Signature date: 22 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KMTS transaction

Common Shares

Options Exercise

Transaction value
Shares: +100,000
Change %: +51%
Price: $17.00^*
Shares after: 295,825
Date: 21 Oct 2026
Ownership: Direct
Footnotes: F1

KMTS transaction

Common Shares

Sale

Transaction value: $2,617,301
Shares: -96,404
Change %: -33%
Price: $27.15
Shares after: 199,421
Date: 21 Oct 2026
Ownership: Direct
Footnotes: F1, F2

KMTS transaction

Common Shares

Sale

Transaction value: $101,017
Shares: -3,596
Change %: -1.8%
Price: $28.09
Shares after: 195,825
Date: 21 Oct 2026
Ownership: Direct
Footnotes: F1, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KMTS transaction Derivative

Options

Options Exercise

Transaction value
Shares: -100,000
Change %: -18%
Price: $0.000000^*
Shares after: 441,000
Date: 21 Oct 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 100,000
Exercise price: $17.00
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

This reported transaction is a scheduled exercise and sale pursuant to a Rule 10b5-1 trading plan adopted on July 21, 2026.

Footnote F2

The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.8050 to $27.7927. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

Footnote F3

The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $27.8200 to $28.4200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.

Footnote F4

Includes 395,919 fully vested options as of the filing date, with the remaining 45,081 options vesting in equal monthly installments through March 6, 2027.

SEC remarks

General Counsel and Chief Adminstrative Officer